News
TNXP
0.1394
+10.63%
0.0134
3 Penny Stocks to Watch Now, 10/01/24
TipRanks · 5d ago
Tonix Pharmaceuticals (TNXP) Has a Promising Pipeline but Faces Financial Challenges
TipRanks · 5d ago
Weekly Report: what happened at TNXP last week (0923-0927)?
Weekly Report · 6d ago
Tonix Pharmaceuticals participates in Endpoints panel at RECOVER workshop
TipRanks · 6d ago
Tonix Pharmaceuticals Announces Participation in Endpoints Panel at the Long COVID Workshop and RECOVER TLC Workshop Convened by the Foundation for the National Institutes of Health (FNIH) and the National Institute of Allergy and Infectious Diseases
Barchart · 6d ago
What's Going On With Tonix Pharmaceuticals Stock Friday?
Benzinga · 09/27 16:10
Tonix Pharma Secures Patent, Bolsters Migraine Treatment Future
TipRanks · 09/27 11:27
Tonix issued U.S. patent covering subcutaneous delivery of Zembrace SymTouch
TipRanks · 09/27 11:10
TONIX PHARMACEUTICALS ANNOUNCES ISSUANCE OF U.S. PATENT COVERING THE SUBCUTANEOUS DELIVERY OF FDA-APPROVED ZEMBRACE® SYMTOUCH® TO TREAT MIGRAINES
Reuters · 09/27 11:00
'Mpox Cases Double In Los Angeles County, Health Officials Urge Vaccination; Los Angeles County Public Health Officials Report Increase, Recommend Prevention Measures' - Pasadena Now
Benzinga · 09/24 15:06
Biden On Sudan Says End This War Now; Let's Move Quickly To Face Mpox Outbreak In Africa
Benzinga · 09/24 14:31
President Biden Will Announce Donation Of 1M MPox Vaccine Doses, At Least $500M To African Countries To Support Their Response To Outbreak
Benzinga · 09/24 09:04
CDC Says No Cases Of Clade IA Mpox Have Been Reported Outside Central African Countries Where Clade IA MPVX Is Endemic
Benzinga · 09/23 17:37
Weekly Report: what happened at TNXP last week (0916-0920)?
Weekly Report · 09/23 11:33
Tonix Pharma Highlights TNX-102 SL at Global Pharmaceutics Conference
TipRanks · 09/23 11:29
Tonix Pharmaceuticals files $300M mixed securities shelf
Seeking Alpha · 09/23 07:03
Tonix Pharmaceuticals Announces Data Presentations on TNX-102 SL for Fibromyalgia at the 11th Global Conference on Pharmaceutics and Novel Drug Delivery Systems (PDDS 2024)
Barchart · 09/23 06:00
TONIX PHARMACEUTICALS HOLDING CORP FILES FOR MIXED SHELF OFFERING OF UPTO $300 MLN- SEC FILING
Reuters · 09/20 21:05
'EMA Recommends Extending Indication Of Mpox Vaccine To Adolescents' - EMA
Benzinga · 09/19 15:41
Looking Into Tonix Pharmaceuticals's Recent Short Interest
Benzinga · 09/19 13:45
More
Webull provides a variety of real-time TNXP stock news. You can receive the latest news about Tonix Pharmaceut through multiple platforms. This information may help you make smarter investment decisions.
About TNXP
Tonix Pharmaceuticals Holding Corp. is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Its development portfolio is focused on central nervous system (CNS) disorders. Its product candidates include Tonmya (TNX-102 SL), TNX-102 SL, TNX-1300, TNX-2900, TNX-1900, TNX-1500, TNX-801 and TNX-1800. TNX-102 SL is for the management of fibromyalgia. Its CNS portfolio includes TNX-1300 (cocaine esterase), a biologic designed to treat cocaine intoxication that has a therapy designation. Its immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. It markets Zembrace SymTouch (sumatriptan injection) 3 mg and Tosymra (sumatriptan nasal spray) 10 mg.